JANSSEN
At Janssen, the pharmaceutical companies of Johnson & Johnson, our mission is to transform individual lives and change fundamentally the way diseases are managed, interpreted, and prevented. Bringing solutions and advancing science for the benefit of patients. They work with today’s informed and empowered patients to ensure our solutions are designed for and reach the people who need them. They work for change that will improve access to medicines: the best available treatment at an affordable price. That’s why they at Janssen strive to provide access to effective and affordable medicines and related health care services across the world.
JANSSEN
Industry:
Health Care Medical Pharmaceutical
Founded:
1953-01-01
Address:
Beerse, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.janssen.com
Total Employee:
10001+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Axel Johnson International AB
Axel Johnson International is a part of the family company Axel Johnson AB.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-02 | Anakuria Therapeutics | Anakuria Therapeutics acquired by Janssen | N/A |
Investors List
RA Capital Management
RA Capital Management investment in Seed Round - Janssen
Newest Events participated
Official Site Inspections
http://www.janssen.com
- Host name: 104.18.42.210
- IP address: 104.18.42.210
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Janssen"
About Janssen Global - Janssen United States
May 5, 2015 This information is intended for use by our customers, patients, and healthcare professionals in the United States only. Janssen Pharmaceuticals, Inc., recognizes that the …See details»
About us - Janssen
Inspired by patients, and the legacy of industry pioneer Dr. Paul Janssen, we continue with the vision of developing science-based innovations to change and save lives. Who we are Who …See details»
Corporate | Johnson & Johnson
2023 Janssen Transparency Report; Resources. Investor FAQs; Information request form; Investor email alerts; Investor contacts; Go to jnj.com; Questions? Please contact us: 1-800 …See details»
Janssen Inc. - LinkedIn
Janssen Inc. | 94,207 followers on LinkedIn. Janssen Inc. (Canada) is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. We are working to create a world without disease by transforming lives by finding new and …See details»
About Janssen - bioadvance.ca
About Janssen. Janssen Inc. is driven by our passionate pursuit of science.We invest in our own research and development efforts while we work to bring innovative ideas, products and …See details»
Janssen Pharmaceuticals - Wikipedia
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson.It was founded in 1953 by Paul Janssen, …See details»
Janssen Inc Company Profile | North York, ON, Canada
Find company research, competitor information, contact details & financial data for Janssen Inc of North York, ON. Get the latest business insights from Dun & Bradstreet.See details»
The Janssen Pharmaceutical Companies of Johnson & Johnson
The Janssen Pharmaceutical Companies of Johnson & Johnson Pharmaceutical Manufacturing Raritan, New Jersey 1,049,734 followersSee details»
Janssen | 2022 Transparency Report
Janssen offers a more detailed look at the price reductions it offer payers and others in the healthcare system to support access to its medicines. ... (JJPAF), an independent, nonprofit …See details»
Janssen - Crunchbase Investor Profile & Investments
At Janssen, the pharmaceutical companies of Johnson & Johnson, our mission is to transform individual lives and change fundamentally the way diseases are managed, interpreted, and …See details»
We are here to transform the future of health - Janssen United …
Sep 26, 2024 This information is intended for use by our customers, patients, and healthcare professionals in the United States only. Janssen Pharmaceuticals, Inc., recognizes that the …See details»
Janssen Announces New Group Targeting Unmet Global Health …
Jan 22, 2014 In September 2013, Janssen entered into a licensing agreement with PATH, an international non-profit organization that transforms global health through innovation, for the …See details»
Introducing Johnson & Johnson Innovative Medicine | Home
Jan 17, 2025 The Janssen Pharmaceutical Companies of Johnson & Johnson is now J&J Innovative Medicine. We’ve been part of Johnson & Johnson and now our identity better …See details»
Janssen Pharmaceuticals - Crunchbase Company Profile & Funding
Janssen Pharmaceuticals reduces the risk of stroke and blood clots in adults and has a medical condition called atrial fibrillation. That is caused by a heart valve problem. The atrial fibrillation, …See details»
Janssen Vaccines - Wikipedia
Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch …See details»
Unternehmenskultur | Janßen Group
So leuchtend, wie die Callunen von Janssen Group sind, so leuchtend ist unsere Zusammenarbeit.” Ihsan Führungskraft Fertigwaren-Produktion vor 4 Jahren als …See details»
Janssen Company Profile - Office Locations, Competitors ... - Craft
Janssen is a company providing prescription pharmaceutical products. It engages in the research, development, and manufacture of medications. The company specializes in the therapeutic …See details»
About us - Janssen Belgium
Inspired by patients and the legacy of industry pioneer Dr. Paul Janssen, we continue with the vision of developing science-based innovations to change and save lives. Today, we pursue …See details»
U.S. FDA approves TREMFYA® (guselkumab), the first and only IL …
Mar 20, 2025 None of Janssen Research & Development, LLC, Janssen Scientific Affairs, LLC, Janssen Biotech, Inc., Janssen-Cilag International NV nor Johnson & Johnson undertakes to …See details»
TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to ...
Apr 4, 2025 Janssen Research & Development, LLC and Janssen Biotech, Inc. are Johnson & Johnson companies. CAUTIONS CONCERNING FORWARD-LOOKING STATEMENTS This …See details»